Combination of Immune Checkpoint Inhibitors with Chemotherapy in Lung Cancer

MLA

Liu W, et al. “Combination of Immune Checkpoint Inhibitors with Chemotherapy in Lung Cancer.” OncoTargets and Therapy, July 2020, pp. 7229–41. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doajarticles..808a971a448ba0341341cde6641520d4&authtype=sso&custid=ns315887.

APA

Liu W, Zhang L, Xiu Z, Guo J, Wang L, Zhou Y, Jiao Y, Sun M, & Cai J. (2020). Combination of Immune Checkpoint Inhibitors with Chemotherapy in Lung Cancer. OncoTargets and Therapy, 7229–7241.

Chicago

Liu W, Zhang L, Xiu Z, Guo J, Wang L, Zhou Y, Jiao Y, Sun M, and Cai J. 2020. “Combination of Immune Checkpoint Inhibitors with Chemotherapy in Lung Cancer.” OncoTargets and Therapy, July, 7229–41. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doajarticles..808a971a448ba0341341cde6641520d4&authtype=sso&custid=ns315887.